845P Vidutolimod + pembrolizumab as 2L+ treatment in patients with anti–PD-1–refractory melanoma and adrenal insufficiency: Subgroup analyses of a phase Ib study
| Autor: | J.M. Kirkwood, Y. Zakharia, D. Davar, E. Buchbinder, T. Medina, A. Daud, A. Ribas, B. Chmielowski, J.J. Niu, G.T. Gibney, K.A. Margolin, A.J. Olszanski, I. Mehmi, T. Sato, M. Shaheen, L. Zhao, D. Bobilev, A.M. Krieg, J. Wooldridge, M. Milhem |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S936 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.07.971 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|